Generic drugs for contemporary, cost-effective disease management As
a leading supplier of high-quality, cost-effective oncology medicines, AxioNovo GmbH makes a vital contribution towards providing patients with outstanding
Biosimilars – generic biologic drugs for disease management, now and in the future A significant reason for ever-increasing healthcare costs is the enormous financial investment involved in developing new medicinal products such as monoclonal antibodies, also known as biologics. Once the patent on a biologic expires, competitive products known as biosimilars or generic biologics flood the market and help contain costs considerably.
As a modern service company, we work closely with partners in the pharmaceutical industry to develop such biosimilars.